Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 18Hematologic Neoplasms 3Neoplasms, Plasma Cell 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Diseases 1Heart Failure, Systolic 1Acute-Phase Reaction 1

Interventions

Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Heart Failure, Systolic × Bortezomib × Clear all
NCT02026505 2019-03-13

Evaluation of Cardiotoxic Effects of Bortezomib

Oregon Health and Science University

Completed
11 enrolled
Plasma cell

Multiple Myeloma, Heart Failure, Systolic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡